Dr. Patricia A. Pellikka, MD

Dr. Pellikka practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Pellikka's NPI, 1316926546, was assigned on January 16, 2006. Dr. Pellikka graduated from Mayo Clinic Alix School of Medicine - Rochester in 1983. Dr. Pellikka holds Minnesota license 28974.

Dr. Pellikka's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Pellikka's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Pellikka to 6 more medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pellikka practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pellikka's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Pellikka is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Pellikka's licenses on file in 7 states: Minnesota, South Dakota, Iowa, Florida, Arizona, Wisconsin and North Dakota.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension and heart failure among the conditions Dr. Pellikka treats.

CMS data shows 409 Medicare services from Dr. Pellikka across 7 procedure codes in 2024, for 286 Medicare patients. Medicare paid $13,228 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Pellikka in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pellikka's median patient age at 64, with 39% women.

In 2024, Dr. Pellikka wrote 40 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $8,491 in total drug cost. In 2017, CMS named 19 claims across 1 drug.

Dr. Pellikka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 529 papers to Dr. Pellikka, published from 2004 to 2025. 2024 was the busiest year, with 36. The most frequent topics are Echocardiography, Stroke Volume and Ventricular Function, Left. Dr. Pellikka has published most often in J Am Soc Echocardiogr. Dr. Pellikka's most frequent co-authors are Sorin V. Pislaru, MD, Vuyisile T. Nkomo, MD and Garvan C. Kane, MD.

Dmand AI links Dr. Pellikka to 4 clinical trials. Conditions studied include Aortic Stenosis, Subvalvular, Cardiovascular Diseases and Carotid Stenosis. Mayo Clinic sponsors the most, 4.

CMS Open Payments shows 32 general payments to Dr. Pellikka from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Alnylam Pharmaceuticals Inc. paid the most, $6,570.

Dmand AI lists 7 awards for Dr. Pellikka, most recently Fellow (FESC) in 2024.

Dr. Pellikka graduated from Mayo Clinic Alix School of Medicine - Rochester in 1983. Dr. Pellikka is a member of ACC, AHA, ASE and European Society of Cardiology.

Dr. Pellikka is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.